清亮饮治疗气阴两虚型玻璃体积血的临床疗效分析
发布时间：2018-11-07 16:57
【摘要】：目的:分析清亮饮治疗气阴两虚型玻璃体积血的临床疗效材料与方法:选取2014年1月-2015年10月在辽宁中医药大学第一附属医院眼科门诊就诊及住院的气阴两虚型玻璃体积血患者50例,61只眼,运用随机数字表的方法,将50例患者分为治疗组(中药组)25例30只眼,对照组(西药组)25例31只眼。治疗组清亮饮煎汤,每日一剂,日二次温服,连服3个月,对照组采用口服卵磷脂络合碘片(沃丽汀),每次3mg,每日3次,连服2个月,之后减至每次1.5mg,每日3次,维持1个月。观察并记录治疗前和治疗后三月患者的视力、玻璃体积血等级变化,并评定临床疗效。结果:1.治疗组、对照组视力与三月前比较差异均有统计学意义(P0.05),说明治疗组、对照组药物对治疗玻璃体积血均有效。治疗三个月后治疗组与对照组视力比较差异有统计学意义(P0.01),说明治疗组与对照组治疗效果不同,治疗组效果要显著优于对照组。2.综合视力与玻璃体积血程度判定,经Ridit分析,治疗组95%CI=(0.3158,0.4884),对照组95%CI=(0.5104,0.6198);两组95%CI无重叠,认为差别有统计学意义,治疗组中药治疗优于对照组。结论:经过临床观察,在治疗后,清亮饮与卵磷脂络合碘片均使视力不同程度提高,玻璃体积血也有所改善;治疗组治疗效果要明显优于西药组。说明中药方剂清亮饮治疗玻璃体积血疗效确切,显著优于卵磷脂络合碘片(沃丽汀)。
[Abstract]:Objective: to analyze the clinical curative effect of Qingliang Yin in the treatment of vitreous volume blood with deficiency of Qi and Yin: selected from January 2014 to October 2015 in the ophthalmological outpatient clinic of the first affiliated Hospital of Liaoning University of traditional Chinese Medicine to see and hospitalized deficiency of Qi and Yin. 50 cases of vitreous blood, Sixty-one eyes were randomly divided into treatment group (Chinese medicine group) and control group (western medicine group, 25 cases and 31 eyes), and 50 patients were divided into treatment group (Chinese medicine group) and control group (western medicine group). The treatment group was treated with Qingliang decoction, once a day, twice a day for 3 months, while the control group was treated with oral lecithin complex iodized tablets (Voriding), 3 times a day, 3 times a day, for 2 months, and then reduced to 1.5 mg per day, 3 times a day. For one month. To observe and record the changes of visual acuity and vitreous hemorrhage grade before treatment and 3 months after treatment, and to evaluate the clinical effect. The result is 1: 1. The visual acuity of the treatment group and the control group were significantly different from those before 3 months (P0.05), which indicated that the treatment group and the control group were effective in the treatment of vitreous hemorrhage. After three months of treatment, the visual acuity of the treatment group and the control group were significantly different (P0.01), which indicated that the therapeutic effect of the treatment group was different from that of the control group, and the effect of the treatment group was significantly better than that of the control group. Comprehensive visual acuity and vitreous hemorrhage degree were determined by Ridit analysis, the treatment group 95 CI = (0.3158 0. 4884), the control group 95 CI = (0.5104 卤0.6198); There was no overlap of 95%CI between the two groups, and the difference was statistically significant, and the treatment group was superior to the control group. Conclusion: after clinical observation, Qingliangyin and Lecithin complex iodine tablets can improve visual acuity and vitreous volume blood in different degree, and the therapeutic effect of the treatment group is better than that of the western medicine group. The results showed that Qingliang decoction was effective in the treatment of vitreous hemorrhage, and was superior to lecithin complex iodine tablets (Vorietine) in the treatment of vitreous hemorrhage.
【学位授予单位】：辽宁中医药大学
【学位级别】：硕士
【学位授予年份】：2016
【分类号】：R276.7
，
本文编号：2316982
[Abstract]:Objective: to analyze the clinical curative effect of Qingliang Yin in the treatment of vitreous volume blood with deficiency of Qi and Yin: selected from January 2014 to October 2015 in the ophthalmological outpatient clinic of the first affiliated Hospital of Liaoning University of traditional Chinese Medicine to see and hospitalized deficiency of Qi and Yin. 50 cases of vitreous blood, Sixty-one eyes were randomly divided into treatment group (Chinese medicine group) and control group (western medicine group, 25 cases and 31 eyes), and 50 patients were divided into treatment group (Chinese medicine group) and control group (western medicine group). The treatment group was treated with Qingliang decoction, once a day, twice a day for 3 months, while the control group was treated with oral lecithin complex iodized tablets (Voriding), 3 times a day, 3 times a day, for 2 months, and then reduced to 1.5 mg per day, 3 times a day. For one month. To observe and record the changes of visual acuity and vitreous hemorrhage grade before treatment and 3 months after treatment, and to evaluate the clinical effect. The result is 1: 1. The visual acuity of the treatment group and the control group were significantly different from those before 3 months (P0.05), which indicated that the treatment group and the control group were effective in the treatment of vitreous hemorrhage. After three months of treatment, the visual acuity of the treatment group and the control group were significantly different (P0.01), which indicated that the therapeutic effect of the treatment group was different from that of the control group, and the effect of the treatment group was significantly better than that of the control group. Comprehensive visual acuity and vitreous hemorrhage degree were determined by Ridit analysis, the treatment group 95 CI = (0.3158 0. 4884), the control group 95 CI = (0.5104 卤0.6198); There was no overlap of 95%CI between the two groups, and the difference was statistically significant, and the treatment group was superior to the control group. Conclusion: after clinical observation, Qingliangyin and Lecithin complex iodine tablets can improve visual acuity and vitreous volume blood in different degree, and the therapeutic effect of the treatment group is better than that of the western medicine group. The results showed that Qingliang decoction was effective in the treatment of vitreous hemorrhage, and was superior to lecithin complex iodine tablets (Vorietine) in the treatment of vitreous hemorrhage.
【学位授予单位】：辽宁中医药大学
【学位级别】：硕士
【学位授予年份】：2016
【分类号】：R276.7
，
本文编号：2316982
本文链接：https://www.wllwen.com/zhongyixuelunwen/2316982.html
最近更新
教材专著
